Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuronal membrane lipid rafts are specialized, highly ordered microdomains within the neuronal plasma membrane, characterized by an enrichment of cholesterol, sphingolipids, and scaffolding proteins such as flotillins (Pike, 2006, J Lipid Res). These domains function as dynamic signaling hubs that compartmentalize and organize various proteins, including neurotransmitter receptors, ion channels, and G-protein coupled receptors, thereby regulating synaptic transmission and plasticity (Sebastião et al., 2013, Front Physiol). In neurodegenerative diseases like Alzheimer's, lipid rafts serve as the primary site for the amyloidogenic processing of amyloid precursor protein (APP) by beta- and gamma-secretases, leading to the accumulation of amyloid-beta plaques (Ehehalt et al., 2003, J Cell Biol). Consequently, these microdomains are considered therapeutic targets for drugs that aim to alter membrane composition, such as statins or polyunsaturated fatty acids, to disrupt the assembly of toxic protein aggregates or modulate aberrant signaling (Simons & Gerl, 2010, Nat Rev Mol Cell Biol). However, because lipid rafts are ubiquitous across various tissues, achieving brain-specific modulation remains a significant pharmacological challenge.
Cholesterol depletion and structural disruption of membrane microdomains to modulate protein-protein interactions and signaling cascades.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuronal membrane lipid raft (NMLR).